Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories.
Ratings
3.5 / 5
2 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Kevin C. Gorman,PhD$13.4B
Market Cap • 22/04/20241992
(há 32 anos)
1996
(28 years ago)
NASDAQ
Listagem
San Diego
Sede • California1.300
N° de Empregados • 2023Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NBIXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.